High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis
Khalil Bourji(University of Padua), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Corinne Charlier(University of Liège), Emmanuel Chatelus(Laboratoire National de Référence), François Singh(University of Dundee), Erika Pigatto(University of Padua), Franco Cozzi(University of Padua), Bernard Gény(Université de Strasbourg), Jacques‐Eric Gottenberg(Centre National de la Recherche Scientifique), Joël Pincemaïl, Alain Meyer(Hôpitaux Universitaires de Strasbourg), Jean-Olivier Defraigne(University of Liège), Leonardo Punzi(Center for Rheumatology)
Cited by 46
Related Papers
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432